Health And Medicine
-
Researchers discover molecular signature for aggressive thyroid cancer
A Vanderbilt study found that a molecular signature that predicts aggressive thyroid cancer could help guide treatment approaches for patients. Read MoreSep 25, 2023
-
VUMC study reveals critical first steps to cancer
A new study by Vanderbilt researchers provides a remarkably detailed view of the earliest events leading to the development of cancer, and of potential new ways to prevent it. Read MoreSep 20, 2023
-
Low-flow cerebrospinal fluid in Huntington’s disease: study
Vanderbilt researchers found reduced net flow of cerebrospinal fluid in Huntington’s disease, which could contribute to mutant protein retention and altered responsiveness to medications delivered via the spinal cord. Read MoreSep 7, 2023
-
Releasing a brake that drives obesity and diabetes
Vanderbilt researchers have uncovered a potential new way to help curb the rapidly rising worldwide prevalence of metabolic disorders, including obesity and diabetes. Read MoreSep 6, 2023
-
MicroRNAs in immune cells help protect against metabolic defects in obesity: study
Vanderbilt researchers have demonstrated that a cluster of microRNAs — small pieces of RNA that regulate gene expression — work in a type of immune cells called macrophages to help protect against metabolic defects in obesity. Read MoreSep 5, 2023
-
Study reveals genomic code for sepsis in the lungs and kidneys
Researchers at Vanderbilt University Medical Center and the Nashville Veterans Affairs Medical Center have “cracked” the genomic code for sepsis in the lungs and kidneys. Read MoreAug 21, 2023
-
Study finds hallmarks of T cell exhaustion within hours of tumor exposure
Vanderbilt researchers found that that T cells become “exhausted” within hours of encountering a tumor, challenging existing ideas about how T cells become dysfunctional. Read MoreAug 3, 2023
-
VUMC receives $28 million to lead national study of COVID-diabetes link
Researchers at Vanderbilt University Medical Center have received a four-year, $28 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to study the relationship between COVID-19 and diabetes. Read MoreAug 2, 2023
-
Nancy Cox receives American Society of Human Genetics Leadership Award
Nancy Cox, PhD, director of the Vanderbilt Genetics Institute, is the recipient of the 2023 ASHG Leadership Award from the American Society of Human Genetics. Read MoreJul 26, 2023
-
Predicting gene expression may speed discovery: study
Researchers at Vanderbilt University Medical Center and the University of Cambridge have developed a method of or predicting gene expression in hard-to-access tissues like the brain from more accessible tissues, including whole blood. Read MoreJul 20, 2023
-
Holowatyj receives National Cancer Institute MERIT Award
Vanderbilt's Andreana Holowatyj, PhD, MSCI, has received the National Cancer Institute’s Method to Extend Research in Time Award to support her ongoing investigation into how early-onset colorectal cancer and its treatments impact reproductive health. Read MoreJul 19, 2023
-
Alzheimer’s genetic risk tracked across sex, race
A Vanderbilt study of genetic risks for cognitive impairment later in life uses data from 32,426 research participants ages 60 and older to elaborate these risks across sex and across the intersection of sex and race. Read MoreJul 17, 2023
-
Study reveals new clue to gastric cancer
Researchers at Vanderbilt University Medical Center have uncovered evidence of fibroblast cells' direct involvement in the development of gastric cancer. Read MoreJul 7, 2023
-
Vanderbilt researchers envision the potential to grow new lungs
Using a four-dimensional microscope that allows them to watch a tissue putting itself together, researchers at Vanderbilt University Medical Center have achieved a rare feat in science — they have shattered a long-standing dogma about how the lung develops. Read MoreJul 5, 2023
-
Persistent inflammatory state found in half of pediatric sepsis deaths: study
New research shows that about half of pediatric patients who died of sepsis over the past 20 years at Vanderbilt University Medical Center had evidence of an inflammatory state called persistent inflammation, immunosuppression and catabolism syndrome. Read MoreJun 29, 2023
-
VUMC, Oxford team develops ‘blueprint’ to block lethal virus
Researchers at Vanderbilt University Medical Center and the University of Oxford have determined how a human monoclonal antibody isolated at Vanderbilt in 2021 can prevent infection by the potentially lethal Sin Nombre virus. Read MoreJun 22, 2023
-
Vanderbilt launches $17 million program to advance diversity of research faculty
Vanderbilt University Medical Center and Vanderbilt University are launching a $17 million multiyear transformative program with support from the National Institutes of Health to accelerate diversity, equity, inclusion and belonging in the biomedical research community. Read MoreJun 21, 2023
-
Early-onset CRC germline genetic differences identified by race, ethnicity
A Vanderbilt study that delved into genetic predisposition for early-onset colorectal cancer by race and ethnicity has identified differing germline risk variants. Read MoreJun 15, 2023
-
Enhanced treatment helps fast nicotine metabolizers quit smoking
A study from Vanderbilt researchers has found that enhanced treatment support can help smokers who have more difficulty quitting because they are fast metabolizers of nicotine. Read MoreJun 8, 2023
-
Byndloss selected for Burroughs Wellcome Fund infectious disease award
Vanderbilt's Mariana Byndloss, DVM, PhD, is one of eight Burroughs Wellcome Fund 2023 Investigators in the Pathogenesis of Infectious Disease. Read MoreJun 7, 2023